To explore the relevance of these different mechanisms in vivo in ischemic stroke, we administered the p62 ZZ domain inhibitor XRK3F2 (2.5 μg/μL) into the lateral ventricle of mice 24 h before transient MCAO (Fig. 10A). Here, SQSTM1 is linked to ischemic stroke.